A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral DensityRobert R. Recker, Stephen L. Myers, Deborah A. Robins et al.|Journal of Bone and Mineral Research|2014Cited by 291
Combination Teriparatide and Raloxifene Therapy for Postmenopausal Osteoporosis: Results From a 6-Month Double-Blind Placebo-Controlled TrialChad Deal, John H. Krege, M. Omizo et al.|Journal of Bone and Mineral Research|2005Cited by 222